This site usescookies, tags, and tracking settings to store information that help give you the very best browsing experience. Dismiss this warning

Search Results

You are looking at1-3of3items for

  • Author or Editor: Anthony K. Frempong-Boadux
  • Refine by Access: allx
Clear All Modify Search
Open access

Yevgenia Sh戴安娜安东尼,罗伯特·g·路易斯ekhtman, Thomas Steineke, Anthony Frempong-Boadu, and Gary K. Steinberg

BACKGROUND

Virtual reality (VR) offers an interactive environment for visualizing the intimate three-dimensional (3D) relationship between a patient’s pathology and surrounding anatomy. The authors present a model for using personalized VR technology, applied across the neurosurgical treatment continuum from the initial consultation to preoperative surgical planning, then to intraoperative navigation, and finally to postoperative visits, for various tumor and vascular pathologies.

OBSERVATIONS

Five adult patients undergoing procedures for spinal cord cavernoma, clinoidal meningioma, anaplastic oligodendroglioma, giant aneurysm, and arteriovenous malformation were included. For each case, 360-degree VR (360°VR) environments developed using Surgical Theater were used for patient consultation, preoperative planning, and/or intraoperative 3D navigation. The custom 360°VR model was rendered from the patient’s preoperative imaging. For two cases, the plan changed after reviewing the patient’s 360°VR model from one based on conventional Digital Imaging and Communications in Medicine imaging.

LESSONS

Live 360° visualization with Surgical Theater in conjunction with surgical navigation helped validate the decisions made intraoperatively. The 360°VR models provided visualization to better understand the lesion’s 3D anatomy, as well as to plan and execute the safest patient-specific approach, rather than a less detailed, more standardized one. In all cases, preoperative planning using the patient’s 360°VR model had a significant impact on the surgical approach.

Restricted access

Stephen P. Kalhorn, Anthony K. Frempong-Boadu, Irina Mikolaenko, Tibor Becske, and David H. Harter

Metameric lesions of the spine are rare. The authors present a case of patient with a complex metameric vascular lesion of the thoracic spine and describe a management strategy for this entity.

Restricted access

Hammad A. Khan, Roee Ber, Sean N. Neifert, David B. Kurland, Ilya Laufer, Douglas Kondziolka, Arpit Chhabra, Anthony K. Frempong-Boadu, and Darryl Lau

OBJECTIVE

通过最小化工件成像和粒子scatter, carbon fiber–reinforced polyetheretherketone (CF-PEEK) spinal implants are hypothesized to enhance radiotherapy (RT) planning/dosing and improve oncological outcomes. However, robust clinical studies comparing tumor surgery outcomes between CF-PEEK and traditional metallic implants are lacking. In this paper, the authors performed a systematic review of the literature with the aim to describe clinical outcomes in patients with spine tumors who received CF-PEEK implants, focusing on implant-related complications and oncological outcomes.

开云体育世界杯赔率

A systematic review of the literature published between database inception and May 2022 was performed in accordance with the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The PubMed database was queried using the terms "carbon fiber" and "spine" or "spinal." The inclusion criteria were articles that described patients with CF-PEEK pedicle screw fixation and had a minimum of 5 patients. Case reports and phantom studies were excluded.

RESULTS

This review included 11 articles with 326 patients (237 with CF-PEEK–based implants and 89 with titanium-based implants). The mean follow-up period was 13.5 months, and most tumors were metastatic (67.1%). The rates of implant-related complications in the CF-PEEK and titanium groups were 7.8% and 4.7%, respectively. The rate of pedicle screw fracture was 1.7% in the CF-PEEK group and 2.4% in the titanium group. The rates of reoperation were 5.7% (with 60.0% because of implant failure or junctional kyphosis) and 4.8% (all because of implant failure or junctional kyphosis) in the CF-PEEK and titanium groups, respectively. When reported, 72.5% of patients received postoperative RT (41.0% stereotactic body RT, 30.8% fractionated RT, 25.6% proton, 2.6% carbon ion). Four articles suggested that implant artifact was reduced in the CF-PEEK group. Local recurrence occurred in 14.4% of CF-PEEK and 10.7% of titanium-implanted patients.

CONCLUSIONS

While CF-PEEK harbors similar implant failure rates to traditional metallic implants with reduced imaging artifact, it remains unclear whether CF-PEEK implants improve oncological outcomes. This study highlights the need for prospective, direct comparative clinical studies.

Baidu
map